PLEASANTON, Calif., Nov. 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that a jury in the U.S. District Court for the District ...
Metastatic prostate cancer (mPC) is a phenotypically diverse disease with poor responses to immune based therapeutics. Development of immunotherapeutic strategies for mPC is hampered by the ...
NanoString Technologies, Inc. #PublicationAlert: Transcriptome-wide in situ hybridisation to spatially map cell types and autism gene expression in the developing human neocortex! The new nanostring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results